Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06307665 | RECRUITING | Asthma

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Sponsor:

AstraZeneca

Brief Summary:

The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of asthma and at least one severe exacerbation in the prior year.

Condition or disease

Asthma

Intervention/treatment

BDA MDI

AS MDI

Phase

PHASE3

Detailed Description:

This is a randomized, double-blind, multicenter, parallel-group Phase IIIb study with a fixed treatment period of 52 weeks. The study will consist of 3 periods: 1. Screening period (7 to 28 days) 2. Treatment period of 52 weeks 3. Safety follow-up period (7 to 14 days after the end of treatment \[EOT\] visit) Participants who meet the eligibility criteria will be randomly assigned to BDA MDI 160/180 micrograms (μg) or AS MDI 180 μg treatment groups in a 1:1 ratio on top of their own usual maintenance therapy during treatment period. This study will also include a pharmacokinetic (PK) sub-study with single visit scheduled after the safety follow-up visit in the main study. During PK sub-study, single dose of open-label BDA MDI 160/180 μg will be administered.

Study Type : INTERVENTIONAL
Estimated Enrollment : 440 participants
Masking : DOUBLE
Primary Purpose : TREATMENT
Official Title : A Randomized, Double-blind, Multicenter, Parallel Group, Phase IIIb 52 Week Study Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma (ACADIA)
Actual Study Start Date : 2024-05-20
Estimated Primary Completion Date : 2027-10-13
Estimated Study Completion Date : 2027-10-13

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 12 Years to 17 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Confirmed clinical diagnosis of asthma at least 12 months.
  • * Receiving one of the following scheduled asthma maintenance therapies for at least 3 months with stable dosing for at least the last one month
  • 1. Low-to-high-dose Inhaled corticosteroid(s) (ICS)
  • 2. Low-to-high-dose ICS with or without long-acting β2-agonist (LABA) and one additional maintenance therapy from the following: leukotriene receptor antagonist (LTRA), long-acting muscarinic antagonist (LAMA), or theophylline
  • * Receiving inhaled short-acting β2-agonist (SABA) as needed.
  • * A documented history of at least one severe asthma exacerbation within 12 months.
  • * Use of Sponsor-provided albuterol sulfate inhalation aerosol medication.
  • * Demonstrate acceptable MDI administration technique as assessed by the investigator; use of spacers is prohibited.
  • * Able to perform acceptable and reproducible peak expiratory flow (PEF) measurements as assessed by the investigator.
  • * Participants must adhere to protocol specific contraception methods.
  • * Negative urine pregnancy test for participants of childbearing potential.
  • * Have a BMI \< 40 kg/ m\^2.
  • * Capable of giving assent (signing the assent form) to participate in the study which includes compliance with the requirements and restrictions. The caregiver of the patient must be capable of giving written informed consent for the patient's participation in the study. Consent and assent forms must be completed prior to any study-specific procedures.
Exclusion Criteria
  • * Life-threatening asthma defined as any history of significant asthma episode(s) requiring intubation associated with hypercapnia, respiratory arrest, hypoxic seizures, or asthma-related syncopal episode(s).
  • * Experienced \> 3 severe asthma exacerbations within 12 months before screening.
  • * Completed treatment for lower respiratory infection and severe asthma exacerbation with SCS within 4 weeks of screening.
  • * Upper respiratory infection involving antibiotic treatment not resolved.
  • * Current smokers, former smokers with \> 10 pack-years history, or former smokers who stopped smoking \< 6 months (including all forms of tobacco, e-cigarettes \[vaping\], and marijuana).
  • * Other significant lung disease, including regular or occasional use of oxygen.
  • * Historical or current evidence of a clinically significant disease including, but not limited to: cardiovascular, hepatic, renal, hematological, neuropsychological, endocrine, or gastrointestinal disorders.
  • * Cancer not in complete remission for at least 5 years.
  • * History or hospitalization for psychiatric disorder or attempted suicide within one year.
  • * Significant abuse of alcohol or drugs, in the opinion of the investigator.
  • * Oral corticosteroid(s) (OCS)/SCS use (any dose and any indication) within 4 weeks before Visit 1 or chronic use of OCS/SCS (≥ 3 weeks use in 3 months prior to Visit 1).
  • * Use of any oral SABAs within one month.
  • * Having a known or suspected hypersensitivity to albuterol/salbutamol, or budesonide and/or their excipients.
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Location Details

NCT06307665

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

NOT YET RECRUITING

United States, Alaska

Research Site

Anchorage, Alaska, United States, 99508

NOT YET RECRUITING

United States, Arizona

Research Site

Gilbert, arizona, United States, 85234

NOT YET RECRUITING

United States, Arkansas

Research Site

Little Rock, arkansas, United States, 72202

RECRUITING

United States, California

Research Site

Mission Viejo, California, United States, 92691

NOT YET RECRUITING

United States, California

Research Site

Orange, California, United States, 92868

NOT YET RECRUITING

United States, California

Research Site

Riverside, California, United States, 92506

NOT YET RECRUITING

United States, California

Research Site

San Diego, California, United States, 92123

NOT YET RECRUITING

United States, California

Research Site

San Francisco, California, United States, 94143

NOT YET RECRUITING

United States, California

Research Site

Westminster, California, United States, 92683

NOT YET RECRUITING

United States, Colorado

Research Site

Denver, Colorado, United States, 80206

NOT YET RECRUITING

United States, Delaware

Research Site

Wilmington, Delaware, United States, 19803

RECRUITING

United States, Florida

Research Site

Destin, Florida, United States, 32541

NOT YET RECRUITING

United States, Florida

Research Site

Jacksonville, Florida, United States, 32207

NOT YET RECRUITING

United States, Florida

Research Site

Miami, Florida, United States, 33145

NOT YET RECRUITING

United States, Florida

Research Site

Seminole, Florida, United States, 33777

NOT YET RECRUITING

United States, Georgia

Research Site

Columbus, Georgia, United States, 31904

NOT YET RECRUITING

United States, Georgia

Research Site

Fayetteville, Georgia, United States, 30214

NOT YET RECRUITING

United States, Illinois

Research Site

Normal, Illinois, United States, 61761

NOT YET RECRUITING

United States, Illinois

Research Site

River Forest, Illinois, United States, 60305

NOT YET RECRUITING

United States, Indiana

Research Site

Indianapolis, Indiana, United States, 46202

NOT YET RECRUITING

United States, Kentucky

Research Site

Louisville, Kentucky, United States, 40202

RECRUITING

United States, Louisiana

Research Site

Lafayette, Louisiana, United States, 70508

NOT YET RECRUITING

United States, Louisiana

Research Site

New Orleans, Louisiana, United States, 70121

NOT YET RECRUITING

United States, Maryland

Research Site

Silver Spring, Maryland, United States, 20902

RECRUITING

United States, Maryland

Research Site

White Marsh, Maryland, United States, 21162

NOT YET RECRUITING

United States, Michigan

Research Site

Detroit, Michigan, United States, 48201

RECRUITING

United States, Minnesota

Research Site

Mankato, Minnesota, United States, 56001

NOT YET RECRUITING

United States, Montana

Research Site

Missoula, Montana, United States, 59804

RECRUITING

United States, Nebraska

Research Site

Lincoln, Nebraska, United States, 68510

NOT YET RECRUITING

United States, Nebraska

Research Site

Omaha, Nebraska, United States, 68114

NOT YET RECRUITING

United States, New Jersey

Research Site

Newark, New Jersey, United States, 07103

NOT YET RECRUITING

United States, New Jersey

Research Site

Northfield, New Jersey, United States, 08225

NOT YET RECRUITING

United States, New Jersey

Research Site

Ocean City, New Jersey, United States, 07712

NOT YET RECRUITING

United States, New Mexico

Research Site

Albuquerque, New Mexico, United States, 87106

NOT YET RECRUITING

United States, New York

Research Site

Bronx, New York, United States, 10459

RECRUITING

United States, New York

Research Site

Cortland, New York, United States, 13045

RECRUITING

United States, New York

Research Site

Hawthorne, New York, United States, 10532

NOT YET RECRUITING

United States, New York

Research Site

Hollis, New York, United States, 11423

NOT YET RECRUITING

United States, New York

Research Site

New York, New York, United States, 10019

NOT YET RECRUITING

United States, New York

Research Site

New York, New York, United States, 10032

NOT YET RECRUITING

United States, New York

Research Site

Rochester, New York, United States, 14607

RECRUITING

United States, New York

Research Site

Vestal, New York, United States, 13850

NOT YET RECRUITING

United States, New York

Research Site

Vestal, New York, United States, 13850

RECRUITING

United States, New York

Research Site

Watertown, New York, United States, 13601

NOT YET RECRUITING

United States, North Carolina

Research Site

Charlotte, North Carolina, United States, 28277

NOT YET RECRUITING

United States, Ohio

Research Site

Cincinnati, Ohio, United States, 45229

NOT YET RECRUITING

United States, Ohio

Research Site

Columbus, Ohio, United States, 43205

NOT YET RECRUITING

United States, Ohio

Research Site

Dayton, Ohio, United States, 45424

RECRUITING

United States, Ohio

Research Site

Toledo, Ohio, United States, 43617

RECRUITING

United States, Oklahoma

Research Site

Oklahoma City, Oklahoma, United States, 73104

RECRUITING

United States, Oklahoma

Research Site

Oklahoma City, Oklahoma, United States, 73120

RECRUITING

United States, Oklahoma

Research Site

Yukon, Oklahoma, United States, 73099

RECRUITING

United States, Pennsylvania

Research Site

Pittsburgh, Pennsylvania, United States, 15241

NOT YET RECRUITING

United States, South Carolina

Research Site

Charleston, South Carolina, United States, 29425

RECRUITING

United States, South Carolina

Research Site

Rock Hill, South Carolina, United States, 29730

RECRUITING

United States, South Dakota

Research Site

Sioux Falls, South Dakota, United States, 57105

NOT YET RECRUITING

United States, Tennessee

Research Site

Nashville, Tennessee, United States, 37232

RECRUITING

United States, Texas

Research Site

Austin, Texas, United States, 78759

NOT YET RECRUITING

United States, Texas

Research Site

Baytown, Texas, United States, 77521

RECRUITING

United States, Texas

Research Site

Beaumont, Texas, United States, 77701

RECRUITING

United States, Texas

Research Site

Corsicana, Texas, United States, 75110

RECRUITING

United States, Texas

Research Site

dallas, Texas, United States, 75231

NOT YET RECRUITING

United States, Texas

Research Site

Frisco, Texas, United States, 75034

RECRUITING

United States, Texas

Research Site

Houston, Texas, United States, 77065

NOT YET RECRUITING

United States, Texas

Research Site

Houston, Texas, United States, 77099

NOT YET RECRUITING

United States, Texas

Research Site

Kerrville, Texas, United States, 78028

NOT YET RECRUITING

United States, Texas

Research Site

McKinney, Texas, United States, 75069

NOT YET RECRUITING

United States, Texas

Research Site

Saint Anthony, Texas, United States, 78215

RECRUITING

United States, Texas

Research Site

Saint Anthony, Texas, United States, 78229

RECRUITING

United States, Utah

Research Site

West Jordan, Utah, United States, 84088

NOT YET RECRUITING

United States, Vermont

Research Site

Burlington, Vermont, United States, 05405

NOT YET RECRUITING

United States, Virginia

Research Site

Burke, Virginia, United States, 22015

RECRUITING

United States, Washington

Research Site

Bellingham, Washington, United States, 98225

NOT YET RECRUITING

United States, Washington

Research Site

Vancouver, Washington, United States, 98664

NOT YET RECRUITING

China,

Research Site

Beijing, China, 100050

NOT YET RECRUITING

China,

Research Site

Beijing, China, 100191

NOT YET RECRUITING

China,

Research Site

Bengbu, China, 233060

NOT YET RECRUITING

China,

Research Site

Chengdu, China, 610066

NOT YET RECRUITING

China,

Research Site

Chongqing, China, 401122

NOT YET RECRUITING

China,

Research Site

Hohhot, China, 10050

NOT YET RECRUITING

China,

Research Site

Mianyang, China, 621000

NOT YET RECRUITING

China,

Research Site

Shanghai, China, 200062

NOT YET RECRUITING

China,

Research Site

Shanghai, China, 200433

NOT YET RECRUITING

China,

Research Site

Shanghai, China,

NOT YET RECRUITING

China,

Research Site

Shenyang, China, 110004

NOT YET RECRUITING

China,

Research Site

Shenzhen, China, 518034

NOT YET RECRUITING

China,

Research Site

Taizhou, China, 318000

NOT YET RECRUITING

China,

Research Site

Tianjin, China, 300052

NOT YET RECRUITING

China,

Research Site

Tianjin, China, 300134

NOT YET RECRUITING

China,

Research Site

Wuhan, China, 430000

NOT YET RECRUITING

China,

Research Site

Which one, China, 133000

NOT YET RECRUITING

China,

Research Site

Zhongshan, China, 528400